Skip to main content
Skip to footer
About Us
News & Inisghts
Contact Us
Diagnostic Database
Diagnostics 101
Digital Cognitive Assessments
About Digital Cognitive Assessments
DCA Test Characteristics
CSF & PET
Blood-Based Biomarkers
About Blood-Based Biomarkers
BBM Performance Standards
BBM Clinical Integration
BBM Educational Resources
Diagnostics 101
Digital Cognitive Assessments
About Digital Cognitive Assessments
DCA Test Characteristics
CSF & PET
Blood-Based Biomarkers
About Blood-Based Biomarkers
BBM Performance Standards
BBM Clinical Integration
BBM Educational Resources
About Us
News & Inisghts
Contact Us
Diagnostic Database
Diagnostics 101
Digital Cognitive Assessments
About Digital Cognitive Assessments
DCA Test Characteristics
CSF & PET
Blood-Based Biomarkers
About Blood-Based Biomarkers
BBM Performance Standards
BBM Clinical Integration
BBM Educational Resources
Category:
Press Releases
The Global CEO Initiative on Alzheimer’s Disease Publishes Consensus Recommendations for Clinic-Based Digital Cognitive Assessments
January 8, 2026
Roche’s Elecsys® pTau181 Becomes the Only FDA-Cleared Blood Test for Use in Primary Care to Rule Out Alzheimer’s-Related Amyloid Pathology
October 13, 2025
The Global CEO Initiative on Alzheimer’s Disease Launches Groundbreaking Alzheimer’s Blood Test Performance Database for Clinicians
March 27, 2025
The Global CEO Initiative on Alzheimer’s Disease Publishes the First Performance Recommendations for Blood-Based Biomarker Tests by Experts in the Field
June 12, 2024
The Global CEO Initiative on Alzheimer’s Disease Announces Expansion of its Blood-Based Biomarker Workgroup in 2024
March 20, 2024
The Global CEO Initiative on Alzheimer’s Disease (CEOi) is excited to announce the second phase of its Blood-based Biomarker (BBM)…
